IRIS Institutional Research Information System - OPENBS Open Archive UniBS

BOSSI, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.109
AS - Asia 8.140
EU - Europa 4.400
SA - Sud America 1.999
AF - Africa 176
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 4
Totale 28.850
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.871
SG - Singapore 2.706
CN - Cina 1.920
HK - Hong Kong 1.845
BR - Brasile 1.721
UA - Ucraina 881
VN - Vietnam 591
DE - Germania 562
IT - Italia 546
IE - Irlanda 385
PL - Polonia 382
TR - Turchia 372
RU - Federazione Russa 359
GB - Regno Unito 323
EE - Estonia 295
FI - Finlandia 211
IN - India 159
AR - Argentina 125
ID - Indonesia 116
CA - Canada 112
SE - Svezia 106
BD - Bangladesh 91
AT - Austria 77
ZA - Sudafrica 72
MX - Messico 71
FR - Francia 69
IQ - Iraq 66
EC - Ecuador 48
PK - Pakistan 42
NL - Olanda 41
CZ - Repubblica Ceca 40
ES - Italia 36
JP - Giappone 36
SA - Arabia Saudita 36
EG - Egitto 32
CO - Colombia 24
PY - Paraguay 23
UZ - Uzbekistan 21
VE - Venezuela 21
MA - Marocco 20
AU - Australia 19
JO - Giordania 19
KE - Kenya 15
CH - Svizzera 14
NP - Nepal 14
PE - Perù 14
IL - Israele 13
BE - Belgio 12
MY - Malesia 12
AZ - Azerbaigian 10
CL - Cile 10
DO - Repubblica Dominicana 10
IR - Iran 9
JM - Giamaica 9
LT - Lituania 9
TN - Tunisia 9
AE - Emirati Arabi Uniti 8
UY - Uruguay 7
AL - Albania 6
CR - Costa Rica 6
DZ - Algeria 6
HR - Croazia 6
KZ - Kazakistan 6
LB - Libano 6
MK - Macedonia 6
NI - Nicaragua 6
OM - Oman 6
PA - Panama 6
BH - Bahrain 5
ET - Etiopia 5
HN - Honduras 5
LY - Libia 5
SN - Senegal 5
DK - Danimarca 4
EU - Europa 4
GR - Grecia 4
KG - Kirghizistan 4
KR - Corea 4
LK - Sri Lanka 4
PH - Filippine 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
BB - Barbados 3
BG - Bulgaria 3
BO - Bolivia 3
BY - Bielorussia 3
MU - Mauritius 3
PT - Portogallo 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
GY - Guiana 2
IS - Islanda 2
KW - Kuwait 2
LU - Lussemburgo 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
PS - Palestinian Territory 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
Totale 28.830
Salva come PNG Salva come JPEG
Città #
Fairfield 2.231
Hong Kong 1.836
Ashburn 1.407
Singapore 1.126
Seattle 919
Woodbridge 898
Jacksonville 848
Houston 787
Cambridge 694
Wilmington 674
Princeton 636
Beijing 520
Dallas 448
New York 419
Chandler 416
Warsaw 375
Dublin 342
Istanbul 319
Tallinn 295
Ann Arbor 282
The Dalles 246
Los Angeles 232
Des Moines 170
Ho Chi Minh City 170
Nanjing 163
Redondo Beach 151
San Diego 151
Helsinki 140
São Paulo 130
Buffalo 120
Hanoi 116
Brescia 112
Moscow 102
Munich 97
London 84
Jakarta 83
Chicago 80
Changsha 74
Shenyang 73
Nuremberg 71
Shanghai 69
San Francisco 68
Milan 59
Dong Ket 58
Jinan 58
Tianjin 58
Nanchang 57
Hebei 52
Jiaxing 51
Brooklyn 48
Johannesburg 43
Menlo Park 43
Santa Clara 42
Pune 41
Belo Horizonte 38
Rio de Janeiro 37
Rome 37
Turku 37
Guangzhou 36
Toronto 35
Brno 33
Vienna 33
Brasília 32
Frankfurt am Main 32
Tokyo 31
Curitiba 30
Salt Lake City 30
Montreal 28
Lappeenranta 27
Ningbo 27
Campinas 26
Haiphong 26
Kilburn 26
Chennai 25
Hangzhou 24
Boston 23
Salvador 23
Norwalk 22
Zhengzhou 22
Poplar 21
Taizhou 21
Atlanta 20
Denver 20
Phoenix 20
Baghdad 19
Da Nang 19
Santo André 19
Stockholm 19
Amman 18
Boardman 18
Cairo 18
Erbil 18
Guayaquil 18
Mexico City 18
Romola 18
Tashkent 18
Manchester 17
Porto Alegre 17
Ribeirão Preto 17
Düsseldorf 16
Totale 19.913
Salva come PNG Salva come JPEG
Nome #
A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck 796
Systematic review of photobiomodulation for the managementof oral mucositis in cancer patients and clinical practice guidelines 273
Systematic review of natural and miscellaneous agents for the management of oral mucositis in cancer patients and clinical practice guidelines-part 1: vitamins, minerals, and nutritional supplements. 207
Prognostic Nomograms in Oral Squamous Cell Carcinoma: The Negative Impact of Low Neutrophil to Lymphocyte Ratio 205
Clinical and histological prognostic factors of recurrent and/or metastatic salivary gland adenoid cystic carcinoma 197
Pretreatment DWI with Histogram Analysis of the ADC in Predicting the Outcome of Advanced Oropharyngeal Cancer with Known Human Papillomavirus Status Treated with Chemoradiation 195
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Dental pathologies and osteoradionecrosis (Part 1) literature review and consensus statement 190
The 8th TNM classification for oral squamous cell carcinoma: What is gained, what is lost, and what is missing 188
Gene expression profiling to improve prognostic characterization of olfactory neuroblastoma and to define new targetable pathways 163
Tumor biomarkers for the prediction of distant metastasis in head and neck squamous cell carcinoma 161
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Xerostomia and trismus (Part 2). Literature review and consensus statement 160
Acute skin toxicity management in head and neck cancer patients treated with radiotherapy and chemotherapy or EGFR inhibitors: Literature review and consensus 155
Malignant tumors of the maxillary sinus: Prognostic impact of neurovascular invasion in a series of 138 patients 151
Gene Expression Clustering and Selected Head and Neck Cancer Gene Signatures Highlight Risk Probability Differences in Oral Premalignant Lesions 151
Systemic therapy in metastatic salivary gland carcinomas: A pathology-driven paradigm? 151
A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact 148
Dysphagia in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus 142
Activity and safety of afatinib in a window preoperative EORTC study in patients with squamous cell carcinoma of the head and neck (SCCHN) 141
Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma 140
Immunotherapy for the prevention of high-risk oral disorders malignant transformation: the IMPEDE trial 139
The Spread of SARS-CoV-2 Infection Among the Medical Oncology Staff of ASST Spedali Civili of Brescia: Efficacy of Preventive Measures 138
Absence of ALK and MET alterations in head and neck sarcomatoid carcinoma 138
Activity of abiraterone in rechallenging two AR-expressing salivary gland adenocarcinomas, resistant to androgen-deprivation therapy 138
Sepsis in head and neck cancer patients treated with chemotherapy and radiation: Literature review and consensus 133
Systematic review of natural and miscellaneous agents, for the management of oral mucositis in cancer patients and clinical practice guidelines - part 2: honey, herbal compounds, saliva stimulants, probiotics, and miscellaneous agents 132
Prognosis and management of recurrent and/or metastatic head and neck adenoid cystic carcinoma 128
Baseline prognostic factors affecting survival in recurrent and/or metastatic salivary gland adenoid cystic carcinoma 125
Precision medicine in rare tumors and the need for multicenter trials and international collaboratives: Sinonasal cancer as paradigm 124
Comprehensive gene expression meta-analysis of head and neck squamous cell carcinoma microarray data defines a robust survival predictor 122
Risk of oral and gastrointestinal mucosal injury among patients receiving selected targeted agents: a meta-analysis 122
Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients 122
Investigational drugs for head and neck cancer 120
Safety and feasibility of every-other-week maintenance cetuximab after first-line chemotherapy in patients with recurrent or metastatic head and neck squamous cell cancer 118
A randomized, double-blind, placebo-controlled, multicenter study of a ginger extract in the management of chemotherapy-induced nausea and vomiting (CINV) in patients receiving high-dose cisplatin 117
Treatment relevant target immunophenotyping of 139 salivary gland carcinomas (SGCs) 115
CISPLATIN DOSE INTENSITY CORRELATES WITH OUTCOME IN PATIENTS WITH LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA RECEIVING CONCURRENT CISPLATIN BASED CHEMORADIATION: A MULTI-INSTITUTIONAL EXPERIENCE 115
Hope in cancer patients: the relational domain as a crucial factor 115
The role of systemic therapy in the management of sinonasal cancer: A critical review 115
Cumulative cisplatin dose in concurrent chemoradiotherapy for head and neck cancer: A systematic review 114
Molecular and cytogenetic subgroups of oropharyngeal squamous cell carcinoma 113
Gene expression profiling of olfactory neuroblastoma helps identify prognostic pathways and define potentially therapeutic targets 113
A European survey on the practice of nutritional interventions in head–neck cancer patients undergoing curative treatment with radio(chemo)therapy 113
A ct-based radiomic signature can be prognostic for 10-months overall survival in metastatic tumors treated with nivolumab: An exploratory study 113
Mining of self-organizing map gene-expression portraits reveals prognostic stratification of HPV-positive head and neck squamous cell carcinoma 111
Receptor tyrosine kinase profiles and human papillomavirus status in oropharyngeal squamous cell carcinoma 110
Multikinase inhibitors in thyroid cancer 110
Assessing Preferences in Patients with Head and Neck Squamous Cell Carcinoma: Phase I and II of Questionnaire Development 110
Outcome of patients with intrathyroidal thymic carcinoma: a pooled analysis 110
Clinical activity of androgen deprivation therapy in patients with metastatic/relapsed androgen receptor-positive salivary gland cancers 109
A NATURAL HISTORY OF A SERIES OF RADIOACTIVE IODINE (131I-RAI)-RESISTANT ADVANCED DIFFERENTIATED THYROID CANCER (DTC) 109
Smoothened (SMO) receptor mutations dictate resistance to vismodegib in basal cell carcinoma 109
Tumor stage, human papillomavirus and smoking status affect the survival of patients with oropharyngeal cancer: an Italian validation study 108
T-cell therapy for EBV-associated nasopharyngeal carcinoma: preparative lymphodepleting chemotherapy does not improve clinical results 107
Treatment-related outcome of oropharyngeal cancer patients differentiated by HPV dictated risk profile: a tertiary cancer centre series analysis 107
Italian version of the MD Anderson Symptom Inventory-Head and Neck Module: linguistic validation 106
The Case Volume Issue in Head and Neck Oncology 106
Circulating pretreatment Epstein Barr Virus DNA quantification as a prognostic factor in nasopharyngeal cancer patients in a non endemic area 105
Health care-associated infections in patients with head and neck cancer treated with chemotherapy and/or radiotherapy 105
TP53 Mutations and Pathologic Complete Response to Neoadjuvant Cisplatin and Fluorouracil Chemotherapy in Resected Oral Cavity Squamous Cell Carcinoma 105
Functional Genomics Uncover the Biology behind the Responsiveness of Head and Neck Squamous Cell Cancer Patients to Cetuximab 105
NICSO: Network Italiano Cure di Supporto in Oncologia - Italian Network for Supportive Care in Oncology 105
Feasibility and activity of docetaxel, cisplatinum and 5-fluorouracil induction chemotherapy followed by concurrent chemo-radiotherapy (including IMRT) in locally advanced undifferentiated nasopharyngeal cancer (LANPC) 105
Primary resistances to EGFR inhibitors (EGFRi) in HPV-positive and -negative oropharyngeal squamous cell carcinoma (OSCC) 105
Not all hematopoietic growth factors are created equal: Should we gain information for their use with immunotherapy? 105
New insights in chemotherapy 104
Gastrointestinal toxicities from targeted therapies: measurement, duration and impact 104
Mucositis in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus statements 104
Folate in head and neck squamous cell cancer chemoprevention: Purposely left out? 103
Evolutionary Action Score of TP53 Coding Variants Is Predictive of Platinum Response in Head and Neck Cancer Patients 103
Circulating pretreatment Epstein Barr Virus DNA quantification as a prognostic factor in nasopharyngeal cancer patients in a non endemic area 103
Nausea and vomiting during the first 3 intercycle periods in chemo-naive cancer patients receiving moderately/highly emetogenic therapy 103
Differential impact of cisplatin dose intensity on human papillomavirus (HPV)-related (+) and HPV-unrelated (-) locoregionally advanced head and neck squamous cell carcinoma (LAHNSCC) 102
Salivary Cytokine Levels and Oral Mucositis in Head and Neck Cancer Patients Treated With Chemotherapy and Radiation Therapy 102
Gene-expression profiles of primary and metastatic lesions in head and neck squamous cell carcinoma 101
Prolonged response using gefitinib followed by sirolimus for advanced cutaneous squamous cell carcinoma 101
Critical analysis of locoregional failures following intensity-modulated radiotherapy for nasopharyngeal carcinoma 101
Optimizing approaches to head and neck cancer. Metastatic head and neck cancer: new options 101
Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II study 101
Head and neck cancer subtypes with biological and clinical relevance: Meta-analysis of gene-expression data 101
TP53 mutations in head and neck cancer 101
The Benefit of a Multidisciplinary Approach to the Patient Treated with (Chemo) Radiation for Head and Neck Cancer 101
Accurate Triage of Oncological Patients for Safely Continuing Cancer Therapy During the SARS-CoV-2 Pandemic 101
Searching for Evidence to Support the Use of Ginger in the Prevention of Chemotherapy-Induced Nausea and Vomiting 100
Resistance to Hedgehog inhibitor through Smoothened receptor mutation in basal cell carcinoma 100
Pain related to cancer treatments and diagnostic procedures: a no man's land? 100
Regional disease in head and neck cutaneous squamous cell carcinoma: the role of primary tumor characteristics and number of nodal metastases 100
Pain management in head and neck cancer patients undergoing chemo-radiotherapy: Clinical practical recommendations 99
Dissecting heterogeneity and molecular mechanisms involved in paranasal sinus cancer 99
Role of EGFR family receptors in proliferation of squamous carcinoma cells induced by wound healing fluids of head and neck cancer patients 99
Isolating p16-positive/HPV-negative Oropharyngeal Cancer: An Effort Worth Making 99
Receptor Tyrosine Kinase Profiles and Human Papillomavirus Status in Oropharyngeal Squamous Cell Carcinoma 99
Emerging tyrosine kinase inhibitors for head and neck cancer 99
Induction chemotherapy within a multimodality treatment of nasal cavity and ethmoid sinus malignant epithelial tumours: report of an homogeneous series of patients 99
Advanced lung cancer inflammation index and its prognostic value in HPV-negative head and neck squamous cell carcinoma: a multicentre study 99
Comments on "Postoperative intensity-modulated radiotherapy following surgery for oral cavity squamous cell carcinoma: Patterns of failure" by Chan and Coll 98
Radiotherapy for unresectable sinonasal cancers: Dosimetric comparison of intensity modulated radiation therapy with coplanar and non-coplanar volumetric modulated arc therapy 98
Prognostic role of PI3KCA and TP53 in HPV-negative oropharyngeal cancers (OPCs) 98
Global cancer control: responding to the growing burden, rising costs and inequalities in access 98
Surveillance of Patients with Head and Neck Cancer with an Intensive Clinical and Radiologic Follow-up 98
A complete remission with androgen-deprivation therapy in a recurrent androgen recptor-expressing adenocarcinoma of the parotid gland [1] 98
Totale 12.725
Salva come PNG Salva come JPEG
Categoria #
all - tutte 184.110
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 184.110
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.116 0 0 0 0 0 729 152 519 345 723 284 364
2021/20222.337 116 253 56 283 109 212 76 202 120 195 201 514
2022/20231.518 359 89 46 113 92 464 8 96 144 26 37 44
2023/20242.385 64 36 117 107 122 577 90 137 665 39 33 398
2024/20255.799 32 21 69 1.028 543 536 336 134 730 555 1.132 683
2025/20267.339 1.063 2.379 1.309 1.712 773 103 0 0 0 0 0 0
Totale 29.261